ARQT
Arcutis Biotherapeutics, Inc.Company with tickers: ARQT
CIK
1787306
CUSIP
03969K108
Shares Outstanding
125,083,374
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $105,398,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $30,627,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-9,089,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-11,295,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-0.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-0.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |